1. Hu D, Liu X, Cheng J, Wang Y, Wang T, Zeng W, Smith H, Garner P: Direct observation and adherence to tuberculosis treatment in Chongqing, China: a descriptive study. Health Policy and Planning 2008, 23:43-55.
2. Sun Q, Meng QY, Yip W, Yin X, Li H: DOT in rural China: experience from a case study in Shandong Province, China. International Journal of Tuberculosis & Lung Disease 2008, 12(6):625-630.
3. Wei X, Walley J, Liang X, Liu F, Zhang X, Li R: Adapting a generic tuberculosis control operational guideline and scaling it up in China: a qualitative case study. BMC Public Health 2008, 8:260:doi:210.1186/1471-2458-1188-1260.
4. Mahtani KR, Heneghan CJ, Glasziou PP, Perera R: Reminder packaging for improving adherence to self-administered long-term medications. Cochrane Database Syst Rev 2011(9):CD005025.
5. Vervloet M, Linn AJ, van Weert JC, de Bakker DH, Bouvy ML, van Dijk L: The effectiveness of interventions using electronic reminders to improve adherence to chronic medication: a systematic review of the literature. J Am Med Inform Assoc 2012, 19(5):696-704.
6. Adjei DN, Agyemang C, Dasah JB, Kuranchie P, Amoah AG: The effect of electronic reminders on risk management among diabetic patients in low resourced settings. J Diabetes Complications 2015, 29(6):818-821.
7. Patel M, Pilcher J, Travers J, Perrin K, Shaw D, Black P, Weatherall M, Beasley R: Use of metered-dose inhaler electronic monitoring in a real-world asthma randomized controlled trial. J Allergy Clin Immunol Pract 2013, 1(1):83-91.
8. O'Dwyer SM, MacHale E, Sulaiman I, Holmes M, Hughes C, D'Arcy S, Rapcan V, Taylor T, Boland F, Bosnic-Anticevich S et al: The effect of providing feedback on inhaler technique and adherence from an electronic audio recording device, INCA(R), in a community pharmacy setting: study protocol for a randomised controlled trial. Trials 2016, 17(1):226.
9. Mokoka MC, Lombard L, MacHale EM, Walsh J, Cushen B, Sulaiman I, Carthy DM, Boland F, Doyle F, Hunt E et al: In patients with severe uncontrolled asthma, does knowledge of adherence and inhaler technique using electronic monitoring improve clinical decision making? A protocol for a randomised controlled trial. BMJ Open 2017, 7(6):e015367.
10. Sutton S, Kinmonth AL, Hardeman W, Hughes D, Boase S, Prevost AT, Kellar I, Graffy J, Griffin S, Farmer A: Does electronic monitoring influence adherence to medication? Randomized controlled trial of measurement reactivity. Ann Behav Med 2014, 48(3):293-299.
11. Checchi KD, Huybrechts KF, Avorn J, Kesselheim AS: Electronic medication packaging devices and medication adherence: a systematic review. JAMA 2014, 312(12):1237-1247.
12. Choudhry NK, Krumme AA, Ercole PM, Girdish C, Tong AY, Khan NF, Brennan TA, Matlin OS, Shrank WH, Franklin JM: Effect of Reminder Devices on Medication Adherence: The REMIND Randomized Clinical Trial. JAMA Intern Med 2017, 177(5):624-631.
13. Saberi P, Johnson MO: Technology-based self-care methods of improving antiretroviral adherence: a systematic review. PLoS One 2011, 6(11):e27533.
14. Wise J, Operario D: Use of electronic reminder devices to improve adherence to antiretroviral therapy: a systematic review. AIDS Patient Care STDS 2008, 22(6):495-504.
15. Liu X, Blaschke T, Thomas B, De Geest S, Jiang S, Gao Y, Li X, Buono EW, Buchanan S, Zhang Z et al: Usability of a Medication Event Reminder Monitor System (MERM) by Providers and Patients to Improve Adherence in the Management of Tuberculosis. Int J Environ Res Public Health 2017, 14(10).
16. Liu X, Lewis JJ, Zhang H, Lu W, Zhang S, Zheng G, Bai L, Li J, Li X, Chen H et al: Effectiveness of Electronic Reminders to Improve Medication Adherence in Tuberculosis Patients: A Cluster-Randomised Trial. PLoS Med 2015, 12(9):e1001876.
17. Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gotzsche PC, Krleza-Jeric K, Hrobjartsson A, Mann H, Dickersin K, Berlin JA et al: SPIRIT 2013 statement: defining standard protocol items for clinical trials. Annals of internal medicine 2013, 158(3):200-207.
18. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M, Medical Research Council G: Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ 2008, 337:a1655.
19. Harden SM, Smith ML, Ory MG, Smith-Ray RL, Estabrooks PA, Glasgow RE: RE-AIM in clinical, community, and corporate settings: Perspectives, strategies, and recommendations to enhance Public Health impact. Frontiers in public health 2018, 6:71.
20. Moore GF, Audrey S, Barker M, Bond L, Bonell C, Hardeman W, Moore L, O'Cathain A, Tinati T, Wight D et al: Process evaluation of complex interventions: Medical Research Council guidance. BMJ 2015, 350:h1258.
21. Wang L, Zhang H, Ruan Y, Chin D, Xia Y, Cheng S: Tuberculosis prevalence in China, 1990-2010; a longitudinal analysis of national survey data. Lancet 2014, 383:2057 - 2064.
22. Li B, Zhang X, Guo J, Wang J, Basang P, Wei X, Yin T, Hu J: The prevalence of pulmonary tuberculosis in Tibet Autonomous Region, China in 2014. The International Journal of Tuberculosis and Lung Disease 2019, accepted.
23. TB CARE I: International Standards for Tuberculosis Care, Edition 3. In. The Hagure: TB CARE I; 2014.
24. Hansson L HT, Dahlf B: Prospective randomized open blinded end-point (PROBE) study: A novel design for intervention trials. Blood pressure 1992, 1(2):113-119.
25. Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, Wagener MM, Singh N: Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000, 133(1):21-30.
26. WHO: Definitions and reporting framework for tuberculosis- 2013 revision. In. Geneva: World Health Orgnaization; 2014.
27. WHO: Guidelines for treatment of tuberculosis. In. Geneva: World Health Organization; 2010.
28. Goldfeld K: Simstudy: Simulation of Study Data. In., R package version 0.1.10. https://CRAN.R-project.org/package=simstudy edn; 2018.
29. Emrich LJ, Piedmonte MR: A Method for Generating High-Dimensional Multivariate Binary Variates. The American Statistician 1991, 45(4):302-304.
30. Højsgaard S, Halekoh U, J. Y: The R Package geepack for Generalized Estimating Equations. Journal of Statistical Software 2006, 15(2):1-11.
31. Pedroza C, Truong VTT: Performance of models for estimating absolute risk difference in multicenter trials with binary outcome. BMC Med Res Methodol 2016, 16:12.
32. Venkatesh V, Morris MG, Davis GB, Davis FD: User Acceptance of Information Technology: Toward a unified view. MIS Quarterly 2003, 27(3):425-478.
33. Haldane V, Tan Y, Teo K, Koh J, Srivastava A, Cheng R, Yap Y, Ong P, van Dam R, Foo J et al: Perspectives on acceptance and use of an mHealth intervention for the prevention of atherosclerotic cardiovascular disease in Singapore: A mixed methods study. JMIR mHealth and uHealth 2018, in press.
34. WHO: Adherence to long-term therapies. In. Geneva: World Health Organization; 2003.
35. Gehrmann U, Kuss O, Wellmann J, Bender R: Logistic regression was preferred to estimate risk differences and numbers needed to be exposed adjusted for covariates. J Clin Epidemiol 2010, 63(11):1223-1231.
36. Vrijens B, De Geest S, Hughes DA, Przemyslaw K, Demonceau J, Ruppar T, Dobbels F, Fargher E, Morrison V, Lewek P et al: A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol 2012, 73(5):691-705.